Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eternal Technologies Group, Inc. was a biotechnology company primarily engaged in the research, development, and commercialization of bio-tech products for human health and agricultural applications. The company gained prominence for its work in transgenic animal cloning, specifically for swine breeding, and the marketing of health supplements such as "Eternal-1," which was promoted for its anti-aging and wellness properties. Based in Haikou, China, with administrative offices in the United States, the company operated through several subsidiaries including Hainan Eternal Bio-Tech. Although it was once publicly traded on the OTC market under the symbol ETTG, the company has since become inactive and is considered a defunct entity in the biotechnology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eternal Technologies Group.